title: Gene expression in skeletal muscle of coronary artery disease patients after concentric and eccentric endurance training.
abstract: Low-intensity concentric (CET) and eccentric (EET) endurance-type training induce specific structural adaptations in skeletal muscle. We evaluated to which extent steady-state adaptations in transcript levels are involved in the compensatory alterations of muscle mitochondria and myofibrils with CET versus EET at a matched metabolic exercise intensity of medicated, stable coronary patients (CAD). Biopsies were obtained from vastus lateralis muscle before and after 8 weeks of CET (n=6) or EET (n=6). Transcript levels for factors involved in mitochondrial biogenesis (PGC-1alpha, Tfam), mitochondrial function (COX-1, COX-4), control of contractile phenotype (MyHC I, IIa, IIx) as well as mechanical stress marker (IGF-I) were quantified using an reverse-transcriptase polymerase chain reaction approach. After 8 weeks of EET, a reduction of the COX-4 mRNA level by 41% and a tendency for a drop in Tfam transcript concentration (-33%, P=0.06) was noted. This down-regulation corresponded to a drop in total mitochondrial volume density. MyHC-IIa transcript levels were specifically decreased after EET, and MyHC-I mRNA showed a trend towards a reduction (P=0.08). Total fiber cross-sectional area was not altered. After CET and EET, the IGF-I mRNA level was significantly increased. The PGC-1alpha significantly correlated with Tfam, and both PGC-1alpha and Tfam significantly correlated with COX-1 and COX-4 mRNAs. Post-hoc analysis identified significant interactions between the concurrent medication and muscular transcript levels as well as fiber size. Our findings support the concept that specific transcriptional adaptations mediate the divergent mitochondrial response of muscle cells to endurance training under different load condition and indicate a mismatch of processes related to muscle hypertrophy in medicated CAD patients.
authors.affiliation: Department of Anatomy, University of Bern, Baltzerstrasse 2, 3000 Bern 9, Switzerland.
authors.forename: J
authors.initials: J
authors.lastname: Zoll
authors.forename: R
authors.initials: R
authors.lastname: Steiner
authors.forename: K
authors.initials: K
authors.lastname: Meyer
authors.forename: M
authors.initials: M
authors.lastname: Vogt
authors.forename: H
authors.initials: H
authors.lastname: Hoppeler
authors.forename: M
authors.initials: M
authors.lastname: Flück
mesh_terms: D000220:Adaptation, Biological; D003324:Coronary Artery Disease / Q000378:metabolism* / Q000503:physiopathology; D015444:Exercise; D015870:Gene Expression; D006801:Humans; D008297:Male; D008928:Mitochondria / Q000378:metabolism; D008931:Mitochondria, Muscle / Q000378:metabolism*; D018485:Muscle Fibers, Skeletal; D018482:Muscle, Skeletal / Q000098:blood supply / Q000378:metabolism* / Q000502:physiology; D010807:Physical Endurance; D012333:RNA, Messenger / Q000378:metabolism*; D014158:Transcription, Genetic
chemical_list: D012333:RNA, Messenger